• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

IL-1 inhibition with anakinra in a patient with refractory gout.

作者信息

Singh Dushyant, Huston K Kwasind

机构信息

Department of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.

出版信息

J Clin Rheumatol. 2009 Oct;15(7):366. doi: 10.1097/RHU.0b013e3181be2423.

DOI:10.1097/RHU.0b013e3181be2423
PMID:20009976
Abstract
摘要

相似文献

1
IL-1 inhibition with anakinra in a patient with refractory gout.用阿那白滞素抑制白细胞介素-1治疗一名难治性痛风患者。
J Clin Rheumatol. 2009 Oct;15(7):366. doi: 10.1097/RHU.0b013e3181be2423.
2
Anakinra's efficacy is variable in refractory gout: report of ten cases.阿那白滞素治疗难治性痛风的疗效不一：10 例报告。
Semin Arthritis Rheum. 2010 Dec;40(3):210-4. doi: 10.1016/j.semarthrit.2010.03.001. Epub 2010 May 21.
3
Case of anakinra as a steroid-sparing agent for gout inflammation.阿那白滞素作为痛风炎症甾体类药物替代剂的病例。
Arthritis Rheum. 2009 Sep 15;61(9):1268-70. doi: 10.1002/art.24694.
4
Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout.阿那白滞素治疗难治性慢性有结晶痛风
Int J Rheum Dis. 2011 Aug;14(3):e33-7. doi: 10.1111/j.1756-185X.2011.01629.x.
5
Utility of Anakinra in Acute Crystalline Diseases: A Retrospective Study Comparing a University Hospital with a Veterans Affairs Medical Center.阿那白滞素在急性晶体性疾病中的应用：一项比较大学医院和退伍军人事务医疗中心的回顾性研究。
J Rheumatol. 2019 Jul;46(7):748-750. doi: 10.3899/jrheum.180393. Epub 2018 Nov 15.
6
Remission of Schnitzler syndrome after treatment with anakinra.使用阿那白滞素治疗后施尼茨勒综合征缓解。
Ann Allergy Asthma Immunol. 2008 Jun;100(6):617-9. doi: 10.1016/S1081-1206(10)60064-6.
7
Efficacy of subcutaneous tocilizumab in a patient with severe gout refractory to anakinra.皮下注射托珠单抗治疗对阿那白滞素难治的重症痛风患者的疗效
Rheumatology (Oxford). 2021 Nov 3;60(11):e375-e377. doi: 10.1093/rheumatology/keab383.
8
[Wells' cellulitis and bacterial necrotizing cellulitis induced by anakinra].
Ann Dermatol Venereol. 2008 Dec;135(12):839-42. doi: 10.1016/j.annder.2008.02.026. Epub 2008 Aug 3.
9
Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.在一例成年斯蒂尔病难治性病例中，尽管出现了瘙痒性皮疹，但仍继续使用阿那白滞素。
Ann Rheum Dis. 2009 Mar;68(3):450-1. doi: 10.1136/ard.2008.093492.
10
IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.施尼茨勒综合征中白细胞介素-1阻断：体外研究结果与临床缓解相关。
J Allergy Clin Immunol. 2008 Jan;121(1):260-2. doi: 10.1016/j.jaci.2007.09.021. Epub 2007 Oct 22.

引用本文的文献

1
Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature.阿那白滞素治疗痛风性关节炎的有效性和安全性：病例系列及文献综述
Front Med (Lausanne). 2023 Jan 12;9:1089993. doi: 10.3389/fmed.2022.1089993. eCollection 2022.
2
POP1 inhibits MSU-induced inflammasome activation and ameliorates gout.POP1 抑制 MSU 诱导的炎症小体激活并改善痛风。
Front Immunol. 2022 Sep 26;13:912069. doi: 10.3389/fimmu.2022.912069. eCollection 2022.
3
Efficacy and safety of gout flare prophylaxis and therapy use in people with chronic kidney disease: a Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)-initiated literature review.
慢性肾脏病患者痛风急性发作预防和治疗的疗效和安全性：痛风、高尿酸血症和晶体相关性疾病网络（G-CAN）发起的文献综述。
Arthritis Res Ther. 2021 Apr 28;23(1):130. doi: 10.1186/s13075-021-02416-y.
4
Medicinal Plants as a Drug Alternative Source for the Antigout Therapy in Morocco.药用植物作为摩洛哥抗痛风治疗的药物替代来源
Scientifica (Cairo). 2020 Nov 23;2020:8637583. doi: 10.1155/2020/8637583. eCollection 2020.
5
Gout increases risk of fracture: A nationwide population-based cohort study.痛风增加骨折风险：一项基于全国人群的队列研究。
Medicine (Baltimore). 2016 Aug;95(34):e4669. doi: 10.1097/MD.0000000000004669.
6
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.白细胞介素-1：从自身炎症性疾病到自身免疫性疾病的共同因素——前提、风险与展望
Mediators Inflamm. 2015;2015:194864. doi: 10.1155/2015/194864. Epub 2015 Feb 16.
7
An expanding role for interleukin-1 blockade from gout to cancer.白细胞介素-1阻断剂从痛风到癌症的作用不断扩展。
Mol Med. 2014 Dec 16;20 Suppl 1(Suppl 1):S43-58. doi: 10.2119/molmed.2014.00232.
8
The emerging role of biotechnological drugs in the treatment of gout.生物技术药物在痛风治疗中的新兴作用。
Biomed Res Int. 2014;2014:264859. doi: 10.1155/2014/264859. Epub 2014 Apr 16.
9
Treating inflammation by blocking interleukin-1 in humans.通过阻断白细胞介素-1 治疗人类炎症。
Semin Immunol. 2013 Dec 15;25(6):469-84. doi: 10.1016/j.smim.2013.10.008. Epub 2013 Nov 23.
10
Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator.利洛纳塞治疗急性痛风性关节炎：一项以吲哚美辛作为活性对照药的随机对照临床试验。
Arthritis Res Ther. 2013 Feb 1;15(1):R25. doi: 10.1186/ar4159.